Oz’s testimony was the first step in securing the votes to become head of the Centers for Medicare and Medicaid Services (CMS ...
The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a post on ...
Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
The FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and ...
Q4 2024 Earnings Call Transcript March 3, 2025 Fractyl Health, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.44. Operator: Good afternoon, and ...
House Bill 1879 passed unanimously March 4 on a 95-0 vote, according to the chamber's website. State senators will now ...
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, told lawmakers on Thursday he would convene a committee ...
The doctor tapped to lead one of America's largest health agencies said millions of children are being drugged to combat the ...
Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health ...
Ascletis Announces Positive ASC47 Phase Ib Pharmacokinetic & Weight Loss Data From Australia Studies
Ascletis Pharma Inc. (ASCLF.PK) announced promising pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection studies conducted in Australia.
Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results